Hollsteen
← IBM

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: $15.1B · 10-Q 0000051143-16-000013 filed Apr 26, 2016Equity incl. NCI · Q2 2016: $15.9B · 10-Q 0001104659-16-134367 filed Jul 26, 2016Equity incl. NCI · Q3 2016: $17.2B · 10-Q 0001104659-16-151931 filed Oct 25, 2016Equity incl. NCI · Q4 2016: $18.4B · 10-K 0001047469-17-001061 filed Feb 28, 2017Equity incl. NCI · Q1 2017: $18.4B · 10-Q 0001104659-17-025881 filed Apr 25, 2017Equity incl. NCI · Q2 2017: $18.5B · 10-Q 0001104659-17-046808 filed Jul 25, 2017Equity incl. NCI · Q3 2017: $19.8B · 10-Q 0001104659-17-064968 filed Oct 31, 2017Equity incl. NCI · Q4 2017: $17.7B · 10-K 0001047469-18-001117 filed Feb 27, 2018Equity incl. NCI · Q1 2018: $18.3B · 10-Q 0001104659-18-026178 filed Apr 24, 2018Equity incl. NCI · Q2 2018: $18.6B · 10-Q 0001104659-18-048404 filed Jul 31, 2018Equity incl. NCI · Q3 2018: $19.9B · 10-Q 0001104659-18-064673 filed Oct 30, 2018Equity incl. NCI · Q4 2018: $16.9B · 10-K 0001047469-19-000712 filed Feb 26, 2019Equity incl. NCI · Q1 2019: $16.6B · 10-Q 0001104659-19-025328 filed Apr 30, 2019Equity incl. NCI · Q2 2019: $17.8B · 10-Q 0001558370-19-006560 filed Jul 30, 2019Equity incl. NCI · Q3 2019: $18.1B · 10-Q 0001558370-19-009324 filed Oct 30, 2019Equity incl. NCI · Q4 2019: $21.0B · 10-K 0001558370-20-001334 filed Feb 25, 2020Equity incl. NCI · Q1 2020: $20.1B · 10-Q 0001558370-20-004491 filed Apr 28, 2020Equity incl. NCI · Q2 2020: $20.7B · 10-Q 0001558370-20-008516 filed Jul 28, 2020Equity incl. NCI · Q3 2020: $21.3B · 10-Q 0001558370-20-011799 filed Oct 27, 2020Equity incl. NCI · Q4 2020: $20.7B · 10-K 0001558370-21-001489 filed Feb 23, 2021Equity incl. NCI · Q1 2021: $21.5B · 10-Q 0001558370-21-004922 filed Apr 27, 2021Equity incl. NCI · Q2 2021: $22.1B · 10-Q 0001558370-21-009351 filed Jul 27, 2021Equity incl. NCI · Q3 2021: $22.4B · 10-Q 0001558370-21-014734 filed Nov 5, 2021Equity incl. NCI · Q4 2021: $19.0B · 10-K 0001558370-22-001584 filed Feb 22, 2022Equity incl. NCI · Q1 2022: $19.1B · 10-Q 0001558370-22-005983 filed Apr 26, 2022Equity incl. NCI · Q2 2022: $19.5B · 10-Q 0001558370-22-010985 filed Jul 25, 2022Equity incl. NCI · Q3 2022: $20.1B · 10-Q 0001558370-22-015322 filed Oct 25, 2022Equity incl. NCI · Q4 2022: $22.0B · 10-K 0001558370-23-002376 filed Feb 28, 2023Equity incl. NCI · Q1 2023: $21.7B · 10-Q 0001558370-23-006656 filed Apr 25, 2023Equity incl. NCI · Q2 2023: $22.3B · 10-Q 0000051143-23-000021 filed Jul 25, 2023Equity incl. NCI · Q3 2023: $23.2B · 10-Q 0000051143-23-000032 filed Oct 31, 2023Equity incl. NCI · Q4 2023: $22.6B · 10-K 0000051143-24-000012 filed Feb 26, 2024Equity incl. NCI · Q1 2024: $23.3B · 10-Q 0000051143-24-000025 filed Apr 30, 2024Equity incl. NCI · Q2 2024: $24.1B · 10-Q 0000051143-24-000039 filed Jul 30, 2024Equity incl. NCI · Q3 2024: $24.5B · 10-Q 0000051143-24-000049 filed Oct 30, 2024Equity incl. NCI · Q4 2024: $27.4B · 10-K 0000051143-25-000015 filed Feb 25, 2025Equity incl. NCI · Q1 2025: $27.0B · 10-Q 0000051143-25-000032 filed Apr 24, 2025Equity incl. NCI · Q2 2025: $27.6B · 10-Q 0000051143-25-000052 filed Jul 24, 2025Equity incl. NCI · Q3 2025: $28.0B · 10-Q 0000051143-25-000064 filed Oct 23, 2025Equity incl. NCI · Q4 2025: $32.7B · 10-K 0000051143-26-000010 filed Feb 24, 2026Equity incl. NCI · Q1 2026: $33.1B · 10-Q 0000051143-26-000038 filed Apr 23, 2026Equity incl. NCI · Q2 2026: $34.5B · 10-Q 0000051143-26-000078 filed Jul 23, 202622.034.515.1Q1 2016Q2 2026Q4 2022
Q4 2022
22.0$B
All values (42)
PeriodValue ($B)Status
Q2 202634.5reported
Q1 202633.1reported
Q4 202532.7reported
Q3 202528.0reported
Q2 202527.6reported
Q1 202527.0reported
Q4 202427.4reported
Q3 202424.5reported
Q2 202424.1reported
Q1 202423.3reported
Q4 202322.6reported
Q3 202323.2reported
Q2 202322.3reported
Q1 202321.7reported
Q4 202222.0reported
Q3 202220.1reported
Q2 202219.5reported
Q1 202219.1reported
Q4 202119.0reported
Q3 202122.4reported
Q2 202122.1reported
Q1 202121.5reported
Q4 202020.7reported
Q3 202021.3reported
Q2 202020.7reported
Q1 202020.1reported
Q4 201921.0reported
Q3 201918.1reported
Q2 201917.8reported
Q1 201916.6reported
Q4 201816.9reported
Q3 201819.9reported
Q2 201818.6reported
Q1 201818.3reported
Q4 201717.7reported
Q3 201719.8reported
Q2 201718.5reported
Q1 201718.4reported
Q4 201618.4reported
Q3 201617.2reported
Q2 201615.9reported
Q1 201615.1reported

CSV with all sources · Technical ID: equity_total

More metrics for IBM
Sources & calculation
Value
$22.0B
Period
Q4 2022, ended Dec 31, 2022 · as of Dec 31, 2022 (balance as of date, not a sum)
Source
10-K, filed Feb 28, 2023 · 0001558370-23-002376
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$22.0BFeb 28, 202310-K 0001558370-23-002376reported · confidence 1. · current